CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Stablepharma aims to transform vaccine distribution by utilizing its StablevaX™ technology, which creates thermostable vaccines that do not require cold storage. This innovation can be applied to over 60 existing vaccines, enhancing global access and reducing waste.
At Stablepharma, our mission is to revolutionise vaccine distribution and storage by leveraging our proprietaryStablevaX™ technology platform which results in the production of vaccines that are thermostable and do not require temperature controlled storage or distribution.
Our technology can be applied to over 60 existing and currently, approved vaccines and our business model enable us to reformulate and thermostabilise existing, vaccines in partnership with vaccine manufacturers.
By eliminati…
STABLEPHARMA LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
